462 studies found for:    Open Studies | "Uterine Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting MK-3475 Immunotherapy in Endometrial Carcinoma
Conditions: Endometrial Cancer;   Endometrial Carcinoma;   Neoplasms, Endometrial
Interventions: Drug: MK-3475;   Procedure: Surgical resection (standard of care);   Drug: Paclitaxel (standard of care);   Drug: Carboplatin (standard of care);   Radiation: Radiation (standard of care);   Procedure: Endometrial biopsy;   Procedure: Peripheral blood draw
22 Not yet recruiting Neoadjuvant Chemotherapy + Surgery Versus Surgery in FIGO IB2 and IIA2 Cervical Cancer
Conditions: PFS;   OS;   Quality of Life
Interventions: Drug: NACT (Paclitaxel + Cisplatin or carboplatin);   Procedure: radical surgery
23 Recruiting the Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP)
Conditions: Cervical Intraepithelial Neoplasia;   Cervical Cancer
Intervention: Drug: Tachosil
24 Recruiting Prospective Study of Fertility-sparing Treatment Strategy in Patients With Early Cervical Cancer(SYSUGO-005)
Condition: Cervical Cancer
Interventions: Drug: Taxane;   Procedure: radical trachelectomy
25 Recruiting Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD
Condition: Menorrhagia
Interventions: Drug: Tranexamic Acid;   Drug: Diosmin
26 Recruiting Study of IMGN853 in Comb. With Bevacizumab, Carboplatin or PLD in Adults With FRa + Adv. EOC, Primary Peritoneal, Fallopian Tube, or Endometrial Cancer
Conditions: Epithelial Ovarian Cancer;   Primary Peritoneal Cancer;   Fallopian Tube Cancer;   Endometrial Cancer
Interventions: Drug: IMGN853;   Drug: Bevacizumab;   Drug: Carboplatin;   Drug: Doxorubicin
27 Not yet recruiting Minimize Menorrhagia in Women With Type 1 Von Willebrand Disease
Condition: Type 1 Von Willebrand Disease
Interventions: Drug: recombinant von Willebrand factor;   Drug: tranexamic acid
28 Recruiting DNA Methylation Biomarkers for Cervical Cancer Screening
Conditions: Cervical Intraepithelial Neoplasia;   Cervical Cancer
Intervention:
29 Not yet recruiting Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence (SENTIRAD).
Condition: Endometrial Carcinoma
Interventions: Drug: Pre-operative Sentinel Node (SN) mapping with Nanocis;   Drug: Intra-operative Sentinel Node (SN) mapping with patent V blue dye;   Drug: Intra-operative Sentinel Node (SN) mapping with indocyanin green (Infracyanine);   Procedure: Full bilateral laparoscopic lymphadenectomy and Hysterectomy
30 Not yet recruiting Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vulvar Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB Vulvar Cancer;   Stage IB2 Cervical Cancer;   Stage II Vulvar Cancer;   Stage IIA1 Cervical Cancer;   Stage IIA2 Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Vulvar Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Vulvar Cancer;   Stage IIIC Vulvar Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vulvar Cancer;   Vulvar Adenocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: High-Dose Rate Brachytherapy;   Radiation: Intensity-Modulated Radiation Therapy;   Radiation: Internal Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Triapine
31 Recruiting Neoadjuvant Chemotherapy and Radical Surgery in Stage IIB Cervical Cancer
Condition: Cervical Carcinoma Stage IIB
Interventions: Radiation: Concurrent chemoirradiation;   Drug: Paclitaxel;   Procedure: Radical Surgery;   Drug: Cisplatin
32 Recruiting Adenomyosis and Ulipristal Acetate
Condition: Adenomyosis
Interventions: Drug: Ulipristal acetate;   Drug: Placebo
33 Recruiting A Phase 1/2a Evaluation of the Safety and Efficacy of Adding AL3818 to Standard Platinum-Based Chemotherapy (AL3818-US-002)
Conditions: Endometrial Carcinoma;   Ovarian Carcinoma;   Fallopian Tube Carcinoma;   Primary Peritoneal Carcinoma;   Cervical Carcinoma
Interventions: Drug: AL3818;   Drug: Carboplatin;   Drug: Paclitaxel
34 Not yet recruiting Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation
Condition: Menorrhagia
Intervention: Other: Ultrasound
35 Recruiting Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies
Conditions: Cervical Carcinoma;   Ovarian Carcinoma;   Primary Peritoneal Carcinoma;   Recurrent Cervical Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Uterine Corpus Carcinoma;   Recurrent Vulvar Carcinoma;   Uterine Corpus Cancer;   Vulvar Carcinoma;   Peritoneal Neoplasms
Interventions: Other: Palliative Therapy;   Other: Palliative Therapy + idiographic
36 Recruiting HPV Integration Testing for Human Papillomavirus-Positive Women
Conditions: Cervical Intraepithelial Neoplasia;   Cervical Cancer
Intervention: Procedure: TCT,HPV,colposcopic inspection
37 Recruiting HPV Integration Testing for Cervical Cancer Screening
Conditions: Cervical Cancer;   Cervical Intraepithelial Neoplasia
Intervention: Procedure: TCT,HPV,colposcopic inspection
38 Not yet recruiting Pilot Study In Vivo Confocal Microscopy Probe for Cervical Precancer
Conditions: Precancerous Condition;   Cervical Cancer
Intervention: Device: In Vivo Confocal Microscopy Probe
39 Not yet recruiting Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC)
Condition: Endometrial Cancer
Interventions: Procedure: Abdominal surgery;   Procedure: Lymphadenectomy
40 Not yet recruiting Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer
Condition: Endometrial Neoplasms
Intervention: Procedure: Sentinel lymph node biopsy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years